| Spacecraft name | EcAMSat (E. Coli AntiMicrobialSat) |
|---|---|
| Form factor | CubeSat |
| Units or mass | 6U |
| Status | Reentry 2021-12-08. Was operational (Last Vladimir (DK3WN) report 2019-05-13 checked on 2019-05-26) |
| Launched | 2017-11-12 |
| NORAD ID | 43019 |
| Deployer | NRCSD (NanoRacks CubeSat Deployer) [Quad-M] |
| Launcher | Antares |
| Deployment | Deployed from ISS on 2017-11-20 |
| Entity name | NASA Ames Research Center |
| Institution | Space agency |
| Entity type | Government (Civil / Military) |
| Nation | US |
| Launch brokerer | Nanoracks |
| Partners | Stanford University |
| Oneliner |
Investigate how and microgravity affects the antibiotic resistance of E. coli |
| Description |
The primary scientific purpose of the EcAMSat mission is to investigate how and whether space microgravity affects the antibiotic resistance of E. coli, a bacterial pathogen responsible for urinary tract infection in humans and animals. |
| Sources | [1] [2] |
| Photo sources | [1] [2] |
| On the same launch |
|
Last modified: 2024-05-29
